158 related articles for article (PubMed ID: 20651388)
41. Carcinoembryonic antigen messenger RNA expression using nested reverse transcription-PCR in the peripheral blood during follow-up period of patients who underwent curative surgery for biliary-pancreatic cancer: longitudinal analyses.
Mataki Y; Takao S; Maemura K; Mori S; Shinchi H; Natsugoe S; Aikou T
Clin Cancer Res; 2004 Jun; 10(11):3807-14. PubMed ID: 15173089
[TBL] [Abstract][Full Text] [Related]
42. Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma.
Nonaka M; Kataoka D; Yamamoto S; Bito A; Matsuoka J; Kawada T; Takaba T
Ann Thorac Cardiovasc Surg; 2004 Oct; 10(5):281-4. PubMed ID: 15563262
[TBL] [Abstract][Full Text] [Related]
43. [The reflection of the dynamics of the serum markers CA l5.3 and CEA in breast cancer].
Cianga C; Suliman I
Rev Med Chir Soc Med Nat Iasi; 1998; 102(3-4):93-5. PubMed ID: 10756852
[TBL] [Abstract][Full Text] [Related]
44. Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study.
Ercan Ş; Kaymaz Ö; Yücel N; Orçun A
Arch Gynecol Obstet; 2012 Mar; 285(3):579-84. PubMed ID: 21792548
[TBL] [Abstract][Full Text] [Related]
45. Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers.
Lee JS; Park S; Park JM; Cho JH; Kim SI; Park BW
Breast Cancer Res Treat; 2013 Oct; 141(3):477-84. PubMed ID: 24072270
[TBL] [Abstract][Full Text] [Related]
46. [Clinical and prognostic significance of preoperative serum CA153, CEA and TPS levels in patients with primary breast cancer].
Chen Y; Zheng YH; Lin YY; Hu MH; Chen YS
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):842-6. PubMed ID: 22335950
[TBL] [Abstract][Full Text] [Related]
47. Prediction of clinical course and recurrence of human ovarian cancer by several serum tumor markers.
Kikuchi Y; Kita T; Iwano I; Kuki E; Oomori K; Kizawa I
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):69-76. PubMed ID: 2926196
[TBL] [Abstract][Full Text] [Related]
48. Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer.
Pedersen AC; Sørensen PD; Jacobsen EH; Madsen JS; Brandslund I
Clin Chem Lab Med; 2013 Jul; 51(7):1511-9. PubMed ID: 23403727
[TBL] [Abstract][Full Text] [Related]
49. [CA 15-3 and CEA markers - prognostic factors in breast cancer].
Anton E; Costăchescu G; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2001; 105(1):161-4. PubMed ID: 12092146
[TBL] [Abstract][Full Text] [Related]
50. The importance of preoperative elevated serum levels of CEA and CA15-3 in patients with breast cancer in predicting its histological type.
Agrawal AK; Jelen M; Rudnicki J; Grzebieniak Z; Zyśko D; Kielan W; Słonina J; Marek G
Folia Histochem Cytobiol; 2010 Jan; 48(1):26-9. PubMed ID: 20529812
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of serum CA27.29, CA15-3 and CEA in patients with breast cancer.
Hou MF; Chen YL; Tseng TF; Lin CM; Chen MS; Huang CJ; Huang YS; Hsieh JS; Huang TJ; Jong SB; Huang YF
Kaohsiung J Med Sci; 1999 Sep; 15(9):520-8. PubMed ID: 10561976
[TBL] [Abstract][Full Text] [Related]
52. Measurement of tumor markers in chronic hemodialysis patients.
Tzitzikos G; Saridi M; Filippopoulou T; Makri A; Goulioti A; Stavropoulos T; Stamatiou K
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):50-3. PubMed ID: 20061692
[TBL] [Abstract][Full Text] [Related]
53. Prognostic role of serum cancer antigen 15-3 in breast cancer patients with isolated bone metastases.
Turanli S; Cetin A
Biomarkers; 2010 Aug; 15(5):418-23. PubMed ID: 20441435
[TBL] [Abstract][Full Text] [Related]
54. [CEA and early detection of relapse in breast cancer subtypes: Comparison with CA 15-3].
Riedinger JM; Goussot V; Desmoulins I; Lorgis V; Coutant C; Beltjens F; Lizard S; Fumoleau P
Bull Cancer; 2016 May; 103(5):434-43. PubMed ID: 26969424
[TBL] [Abstract][Full Text] [Related]
55. Could serum visfatin be a potential biomarker for postmenopausal breast cancer?
Dalamaga M; Archondakis S; Sotiropoulos G; Karmaniolas K; Pelekanos N; Papadavid E; Lekka A
Maturitas; 2012 Mar; 71(3):301-8. PubMed ID: 22261365
[TBL] [Abstract][Full Text] [Related]
56. Preoperative CA 15-3 levels predict the prognosis of nonmetastatic luminal A breast cancer.
Li H; Chen K; Su F; Song E; Gong C
J Surg Res; 2014 Jun; 189(1):48-56. PubMed ID: 24680287
[TBL] [Abstract][Full Text] [Related]
57. Increased serum CA-15.3 levels in patients with megaloblastic anemia due to vitamin B12 deficiency.
Symeonidis A; Kouraklis-Symeonidis A; Apostolopoulos D; Arvanitopoulou E; Giannakoulas N; Vassilakos P; Zoumbos N
Oncology; 2004; 67(5-6):359-67. PubMed ID: 15713991
[TBL] [Abstract][Full Text] [Related]
58. The relationship between circulating carcinoembryonic antigen (CEA) levels and parameters of primary tumor and metastases in breast cancer patients.
Mujagić Z; Mujagic H; Prnjavorac B
Med Arh; 2004; 58(1):23-6. PubMed ID: 15017899
[TBL] [Abstract][Full Text] [Related]
59. Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3.
Molina R; Jo J; Zanón G; Filella X; Farrus B; Muñoz M; Latre ML; Pahisa J; Velasco M; Fernandez P; Estapé J; Ballesta AM
Br J Cancer; 1996 Oct; 74(7):1126-31. PubMed ID: 8855986
[TBL] [Abstract][Full Text] [Related]
60. Comparison of serum CA15-3 and CEA in breast cancer.
Hou MF; Huang TJ; Hsieh JS; Huang YS; Huang CJ; Chan HM; Wang JY; Chen YL; Jong SB; Yang CC
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Dec; 11(12):660-6. PubMed ID: 8551526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]